對於末期腎衰竭的病人,透析治療是目前維持生命最重要的治療。但隨治療成功生命延續,也帶來龐大醫療費用,而且死亡率的下降和人口老化等因素也使透析的醫療費用持續成長,成為公共衛生和社會福利的重大議題。 為了應對龐大醫療費用的成長,健保局採取總額給付浮動點值的政策,政策的改變也牽連整體醫療生態的變動,甚至整合成新的business model , 因此本文從保險制度對人民就醫習慣改變,應用機會成本的觀念重新檢視末期腎衰竭病人的治療成本(包括直接醫療成本、罹病的社會成本、早逝成本、病人回歸社會的經濟效益)。 其次探討不同的成本結構或利潤池的影響,總額給付浮動點值對透析產業和醫療資源應用的影響,經營模式整合的原因和這些經營模式動態競爭下的最適策略和變化。 我們得到以下結論: 1. 比較2002年和2004年,可以看到在總額制度浮動點值確實降低透析病患直接的醫療支出,但在門診、住院和急診數量都明顯上升,是否透析降低的醫療支出,其實是來自醫院診所大總額(不含透析的總額)的彌補?或是其他與透析品質有關的因素?值得深思。 2. 末期腎臟病的病人是高醫療支出的疾病,而且付出高額社會經濟成本,因此如何預防末期腎臟病應該是努力目標。為了減少成本和支出,政府應該投入更多資源在慢性腎臟病照護網,效益較高的末期腎臟病前期處理。 3. 從直接療醫療成本和社會成本效益分析,提高透析品質、增加末期腎臟病的病人回歸社會和就業率,可以實質上減輕社會資源耗費, 4. 提高腹膜透析和腎臟移植比率,可以減少直接醫療成本和社會成本。政府在成本考量下,會是未來推動的治療驅勢,就不同經營模式者,應考慮其對血液透析的替代效應,儘速早考慮競爭策略。 5. 在總額浮動點值下,透析院所最大獲利或賽局的均衡的透析治療量,和變動成本成反比,和健保單次透析給付額成正比,和固定成本無關。 6. 在總額浮動點值下,營運模式會重新整合,醫師自營模式會向供應商垂直整合或醫師策略聯盟移動。 7. 差異化優勢會是未來競爭力重點,應該在學習和成長構面、組織內部的構面、顧客構面,形成新的差異化優勢。
The hemodialysis is the important treatment in the uremic ( ie : end stage of renal disease ) patients .The medical expense and cost will get increased followed the successes treatment .The expansions of medical expense make to be a theme for discussion in the insurance of health care . The policy of total budget with floating payment by Health Insurance impact the ecological dispersion of clinics and hospitals . The change of policy resulted into new business models in the dialysis medical industry . We try to discuss the influence of health insurance about patients 、 clinicss and hospitals , the different forced powers to the dialysis medical industry .We try to re-evaluate the medical cost 、the social economic cost and the social benefit in dialysis treatments for uremic patients by the view of opportunity cost . Then we try to analysis the cost construction of different business models . After analysis of SWOT and game theory , We try to make the strategy for the dialysis medical industry . Our conclusions are as the following : 1. After comparison of medical cost between 2002 and 2004 , the dialysis expense got decreased after he policy of total budget with floating payment .But the charge of emergency care 、OPD and hospitalization got significant increased in the during time . The nature of event need more study . 2. We should put more resource into pre-uremic care . We should set up the chronic care network . 3. Maintain the good and adequate dialysis , make the social benefit about uremic patient return the work . 4. The peritoneal dialysis and transplantation can decrease the medical expense .The government will promote the treatments under the finical stress .We should modify our strategy to enter these fields . 5. Variable cost should to be the dominant factor to the competition of dialysis business models . 6. The integration of different business models will accelerate by the policy of total budget with floating payment . 7. Segmentation will be an important competitive strategy . We should re-design the our strategy maps .